AAAAAA

   
Results: 1-10 |
Results: 10
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test
Authors: Redgrave, TG Watts, GF Martins, IJ Barrett, PHR Mamo, JCL Dimmitt, SB Marais, AD
Citation: Tg. Redgrave et al., Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test, J LIPID RES, 42(5), 2001, pp. 710-715
Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test
Authors: Watts, GF Barrett, PHR Marais, AD Dane-Stewart, CA Martins, IJ Dimmitt, SB Redgrave, TG
Citation: Gf. Watts et al., Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test, ATHEROSCLER, 157(2), 2001, pp. 519-523
Therapeutic modulation of low-density lipoprotein sire
Authors: Marais, AD
Citation: Ad. Marais, Therapeutic modulation of low-density lipoprotein sire, CURR OP LIP, 11(6), 2000, pp. 597-602
Diagnosis, management and prevention of the common dyslipidaemias in SouthAfrica - Clinical guideline, 2000
Authors: Berger, GMB Marais, AD
Citation: Gmb. Berger et Ad. Marais, Diagnosis, management and prevention of the common dyslipidaemias in SouthAfrica - Clinical guideline, 2000, S AFR MED J, 90(2), 2000, pp. 164
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis
Authors: Clee, SM Bissada, N Miao, FD Miao, L Marais, AD Henderson, HE Steures, P McManus, J McManus, B LeBoeuf, RC Kastelein, JJP Hayden, MR
Citation: Sm. Clee et al., Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis, J LIPID RES, 41(4), 2000, pp. 521-531
Inhibition of cholesterol synthesis by atorvastatin in homozygous familialhypercholesterolaemia
Authors: Raal, FJ Pappu, AS Illingworth, DR Pilcher, GJ Marais, AD Firth, JC Kotze, MJ Heinonen, TM Black, DM
Citation: Fj. Raal et al., Inhibition of cholesterol synthesis by atorvastatin in homozygous familialhypercholesterolaemia, ATHEROSCLER, 150(2), 2000, pp. 421-428
Mutation-59c -> t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South Africanfamily with familial hypercholesterolaemia
Authors: Scholtz, CL Peeters, AV Hoogendijk, CF Thiart, R de Villiers, JNP Hillermann, R Liu, JW Marais, AD Kotze, MJ
Citation: Cl. Scholtz et al., Mutation-59c -> t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South Africanfamily with familial hypercholesterolaemia, HUM MOL GEN, 8(11), 1999, pp. 2025-2030
Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men
Authors: Hislop, MS Ratanjee, BD Soule, SG Marais, AD
Citation: Ms. Hislop et al., Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men, EUR J ENDOC, 141(1), 1999, pp. 40-46
Founder mutations in the LDL receptor gene contribute significantly to thefamilial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry
Authors: Loubser, O Marais, AD Kotze, MJ Godenir, N Thiart, R Scholtz, CL de Villiers, JNP Hillermann, R Firth, JC Weich, HFH Maritz, F Jones, S van der Westhuyzen, DR
Citation: O. Loubser et al., Founder mutations in the LDL receptor gene contribute significantly to thefamilial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry, CLIN GENET, 55(5), 1999, pp. 340-345
Follow-up on primary prevention trials
Authors: Marais, AD
Citation: Ad. Marais, Follow-up on primary prevention trials, CURR OP LIP, 9(6), 1998, pp. 551-556
Risultati: 1-10 |